Abstract PS3-10-03: Genomic Platform (GP) Testing and Adjuvant Chemotherapy (CT) Use in Early-Stage hormone receptor-positive (HR+) /HER2 negative (HER2-) Breast Cancer (BC): Real-World Insights and Prognostic Factors
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: R. Urbano, R. García, A. Beltran, M. Martin-Salvago, A. Cano, A. Jaén, P. Sánchez-Rovira
Institution: Complejo Hospitalario de Jaén
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129554091
Cites:
Cited by:
Related to: